Journal of Veterinary Pharmacology and Therapeutics

Papers
(The TQCC of Journal of Veterinary Pharmacology and Therapeutics is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal41
A history of antimicrobial drugs in animals: Evolution and revolution37
Current review of isoxazoline ectoparasiticides used in veterinary medicine32
The challenges and applications of nanotechnology against bacterial resistance20
Physiological parameter values for physiologically based pharmacokinetic models in food‐producing animals. Part I: Cattle and swine18
Antimicrobial drug residues in animal‐derived foods: Potential impact on the human intestinal microbiome14
Pharmacokinetic comparison of six anthelmintics in sheep, goats, and cattle13
Physiological parameter values for physiologically based pharmacokinetic models in food‐producing animals. Part III: Sheep and goat12
Antimicrobial agent use in small animals what are the prescribing practices, use of PK‐PD principles, and extralabel use in the United States?12
Pharmacokinetics of tolfenamic acid after different administration routes in geese (Anser cygnoides)12
Predicting antimicrobial susceptibility from the bacterial genome: A new paradigm for one health resistance monitoring11
Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low‐THC Cannabis sativa extract in beagles11
Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib10
Recent advances in microencapsulation of drugs for veterinary applications10
Effect of castration procedure on the pharmacokinetics of meloxicam in goat kids9
Pharmacokinetics of meloxicam, carprofen, and tolfenamic acid after intramuscular and oral administration in Japanese quails (Coturnix coturnix japonica)9
Physiological parameter values for physiologically based pharmacokinetic models in food‐producing animals. Part II: Chicken and turkey9
Pharmacokinetics and bioavailability of meloxicam in rainbow trout (Oncorhynchus mykiss) broodstock following intravascular, intramuscular, and oral administrations9
Canine and feline P‐glycoprotein deficiency: What we know and where we need to go8
Pharmacokinetics of acetaminophen after intravenous and oral administration in fasted and fed Labrador Retriever dogs8
Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs (Cavia porcellus)8
Pour‐on administration of eprinomectin to lactating dairy goats: Pharmacokinetics and anthelmintic efficacy8
Pharmacokinetics of tolfenamic acid in goats after different administration routes8
Current review of hemp‐based medicines in dogs7
Single dose and chronic oral administration of cannabigerol and cannabigerolic acid‐rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation7
What a veterinary graduate should know about basic and clinical pharmacology: A Delphi study to finalize day‐1 competencies7
In vitro and in vivo evaluation of a new phytotherapic blend to treat acute externa otitis in dogs7
Perioperative pharmacokinetics and pharmacodynamics of meloxicam in emus (Dromaius novaehollandiae) of different age groups using nonlinear mixed effect modelling7
Effect of dose on the intravenous pharmacokinetics of tolfenamic acid in goats7
Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses7
Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine7
Pharmacokinetics of enflicoxib in dogs: Effects of prandial state and repeated administration6
Equine antimicrobial therapy: Current and past issues facing practitioners6
Phenylpiperidine opioid effects on isoflurane minimum alveolar concentration in cats6
Pharmacokinetics of tolfenamic acid in green sea turtles (Chelonia mydas) after intravenous and intramuscular administration6
Application of α2‐adrenergic agonists combined with anesthetics and their implication in pulmonary intravascular macrophages‐insulted pulmonary edema and hypoxemia in ruminants6
Pharmacokinetics of magnesium and its effects on clinical variables following experimentally induced hypermagnesemia6
Concentration profiles and safety of topically applied betulinic acid and NVX‐207 in eight healthy horses—A randomized, blinded, placebo‐controlled, crossover pilot study6
The pharmacokinetic characteristics of sulfadiazine in channel catfish (Ictalurus punctatus) following oral and intravenous administrations6
Analysis of polymorphisms of canine Cytochrome P 450‐CYP2D155
Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses5
Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats5
Clinical pharmacokinetics and outcomes of oral fluconazole therapy in dogs and cats with naturally occurring fungal disease5
Validating an empiric sulfadiazine–trimethoprim dosage regimen for treatment of Escherichia coli and Staphylococcus delphini infections in mink (Neovison vison)5
Grapiprant: A snapshot of the current knowledge5
Pharmacokinetics of paracetamol in the Thoroughbred horse following an oral multi‐dose administration5
Robenacoxib pharmacokinetics in sheep following oral, subcutaneous, and intravenous administration5
Pharmacokinetics of a cytosine arabinoside subcutaneous protocol in dogs with meningoencephalomyelitis of unknown aetiology5
Pharmacokinetics of single and repeated oral doses of pregabalin oral solution formulation in cats5
A review on the treatment and control of ectoparasite infestations in equids5
Pharmacometabolomics with a combination of PLS‐DA and random forest algorithm analyses reveal meloxicam alters feline plasma metabolite profiles5
Sulfadiazine pharmacokinetics in grass carp (Ctenopharyngodon idellus) receiving oral and intravenous administrations5
Pharmacokinetics and bioavailability of tildipirosin in rabbits following single‐dose intravenous and intramuscular administration4
PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli4
Dosing protocols to increase the efficacy of butorphanol in dogs4
Application of physiologically based pharmacokinetic models to promote the development of veterinary drugs with high efficacy and safety4
Pharmacokinetics of a single dose of Aficamten (CK‐274) on cardiac contractility in a A31PMYBPC3 hypertrophic cardiomyopathy cat model4
Bath immersion pharmacokinetics of florfenicol in Nile tilapia (Oreochromis niloticus)4
Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic–pharmacodynamic modeling4
Applying metabolomics to veterinary pharmacology and therapeutics4
Pharmacokinetics of robenacoxib following single intravenous, subcutaneous and oral administrations in Baladi goats (Capra hircus)4
Pharmacokinetics of a sulfadiazine and trimethoprim suspension in neonatal foals4
Doxycycline pharmacokinetics in geese4
Pharmacokinetics of meloxicam in laying hens after single intravenous, oral, and intramuscular administration4
Pharmacokinetics and pharmacodynamics of doxycycline in a Streptococcusequi subsp. zooepidemicus infection model in horses4
Pharmacokinetics and bioavailability of solid dispersion formulation of tilmicosin in pigs4
Pharmacokinetics of ketorolac in juvenile loggerhead sea turtles (Caretta caretta) after a single intramuscular injection4
Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL‐31‐induced pruritus4
Pharmacokinetics and effects on clinical and physiological parameters following a single bolus dose of propofol in common marmosets (Callithrix jacchus)4
Effect of ketoprofen co‐administration on pharmacokinetics of cefquinome following repeated administration in goats4
Determination of colistin in luminal and parietal intestinal matrices of chicken by ultra‐high‐performance liquid chromatography‐tandem mass spectrometry4
Pharmacokinetics of ceftiofur sodium in Peekapoo dogs following a single intravenous and subcutaneous injection3
Association of cytochrome P450 2D15 (CYP2D15) nonsynonymous polymorphisms and exon 3 deleted RNA splice variant with CYP2D15 protein content and enzyme function in dog liver microsomes3
Comparative pharmacokinetics of florfenicol in heifers after intramuscular and subcutaneous administration3
Pharmacokinetic characteristics of danofloxacin in green sea (Chelonia mydas) and hawksbill sea (Eretmochelys imbricata) turtles3
Multidose pharmacokinetics and safety of a modified, compounded theophylline product in dogs3
In vitro efficacy and pharmacodynamic profiles of four polyether ionophores against methicillin‐resistant Staphylococcus spp.3
Effects of dobutamine on cardiovascular function and oxygen delivery in standing horses3
Cefovecin pharmacokinetics after single‐dose intramuscular administration in cheetahs (Acinonyx jubatus)3
Pharmacokinetics of furosemide in goats following intravenous, intramuscular, and subcutaneous administrations3
Plasma disposition of ceftazidime in healthy neonatal foals following intravenous and intramuscular administration3
The bioavailability and pharmacokinetics of an amoxicillin–clavulanic acid granular combination after intravenous and oral administration in swine3
Pharmacokinetics of doxycycline after oral administration of multiple doses in dogs3
Pharmacokinetics of danofloxacin after single oral and intravenous administration in non‐laying hens3
Pharmacokinetics of butorphanol in male neutered cats anesthetized with isoflurane3
Pharmacokinetics of cefquinome in rainbow trout (Oncorhynchus mykiss) after intravascular, intraperitoneal, and oral administrations3
Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs3
Pharmacokinetics, bioavailability, and tissue disposal profiles of Tiamulin fumarate in Nile tilapia (Oreochromis niloticus) following oral and intravenous administrations3
Influence of Escherichia coli endotoxemia on danofloxacin pharmacokinetics in broilers following single oral administration3
Age‐related changes in the pharmacokinetics of meloxicam after intravenous administration in sheep3
Pseudomonas aeruginosa susceptibility, antibiogram and clinical interpretation, and antimicrobial prescribing behaviors for dogs with otitis in the Midwestern United States3
A review of current chemistry, pharmacology, and regulation of endogenous anabolic steroids testosterone, boldenone, and nandrolone in horses3
Oral and topical extra‐label administration of fipronil to laying hens: Assessment of the egg residue patterns3
Single‐dose pharmacokinetics and bioavailability of a novel extended duration transdermal buprenorphine solution in cats3
Pharmacokinetic profiles of three dose rates of morphine sulfate following single intravenous, intramuscular, and subcutaneous administration in the goat3
Metabolism and residue differences of Enrofloxacin between the brain and peripheral tissues and the resulting brain damages in crucian carp (Carassius auratus var. Pengze)3
Enrofloxacin and its major metabolite ciprofloxacin in green sea turtles (Chelonia mydas): An explorative pharmacokinetic study3
Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: Relevance for doping control3
Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1‐1Δ3
Determination of the route of excretion of robenacoxib (Onsior™) in cats and dogs: A pilot study3
Comparative bioavailability of enrofloxacin in dogs when concealed in noncommercial morsels, either as tablet or as enrofloxacin–alginate dried beads3
Pharmacokinetics and anti‐nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea2
Oral pharmacokinetic profile of fipronil and efficacy against flea and tick in dogs2
Pharmacokinetics of dipyrone in horses: A multi‐dose, dose escalation study2
Selective inhibition of cyclooxygenase‐2 by enflicoxib, its enantiomers and its main metabolites in vitro in canine blood2
Pharmacokinetics of fluoxetine in horses following oral administration2
Co‐formulation of ketoprofen with tulathromycin alters pharmacokinetic and pharmacodynamic profile of ketoprofen in cattle2
Assessment of verdinexor as a canine P‐glycoprotein substrate2
Effect of combinations of morphine, dexmedetomidine and maropitant on the electroencephalogram in response to acute electrical stimulation in anaesthetized dogs2
Surface distribution of pyrethroids following topical application to veterinary species: Implications for lateral transport2
A pilot study comparing the pharmacokinetics of injectable cyanocobalamin and hydroxocobalamin associated with a trace mineral injection in cattle2
Pharmacodynamics and plasma concentrations of dexmedetomidine with or without vatinoxan as a constant‐rate infusion in horses anaesthetized with isoflurane—A pilot study2
Pharmacokinetics and milk excretion pattern of eprinomectin at different dose rates in dairy cattle2
The pharmacokinetics and antiparasitic activity of ivermectin in Hutsul and Toric horses2
Pharmacokinetic properties of metamizole active metabolites in Northeastern Brazilian donkeys (Equus asinus)2
Pharmacokinetics of oral firocoxib in un‐weaned calves2
Pharmacokinetics and bioavailability of furosemide in sheep2
Pharmacokinetics of grapiprant and effects on TNF‐alpha concentrations following oral administration to horses2
Effect of ketoprofen and tolfenamic acid on intravenous pharmacokinetics of ceftriaxone in sheep2
Pharmacokinetics and bioavailability of danofloxacin in swan geese (Anser cygnoides) following intravenous, intramuscular, subcutaneous, and oral administrations2
The future of veterinary pharmacology education; veterinary educators in pharmacology: A new special interest group2
Pharmacokinetic profile of a single dose of an oral pradofloxacin suspension administered to eastern long‐necked turtles (Chelodina longicollis)2
The effect of breed, sex, and drug concentration on the pharmacokinetic profile of ivermectin in cattle2
Midazolam oxidation in cattle liver microsomes: The role of cytochrome P450 3A2
PK/PD modelling of enrofloxacin against Glaesserella parasuis infection in pigs2
Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beagles2
Rational determination of cefazolin dosage regimen in horses based on pharmacokinetics/pharmacodynamics principles and Monte Carlo simulations2
Pharmacokinetics of single dose oral Terbinafine in common shelducks (Tadorna tadorna)2
Pharmacokinetic/pharmacodynamic modeling of ketoprofen and flunixin at piglet castration and tail‐docking2
The plasma and tissue kinetics of sulfadiazine and its metabolite in Ictalurus punctatus after oral gavage at two temperatures2
Doxycycline serum protein binding in pigs reveals a relatively high free fraction2
Identification and characterization of the enzymes responsible for the metabolism of the non‐steroidal anti‐inflammatory drugs, flunixin meglumine and phenylbutazone, in horses2
Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep2
Investigation of monensin Type A medicated article dissolution profiles in biorelevant media2
A novel transdermal ketoprofen formulation for analgesia in cattle2
Safety of torasemide in healthy adult dogs administered daily for 26 weeks2
Effects of verapamil on the pharmacokinetics of ivermectin in rabbits2
Examination of the pharmacokinetics and differential inhibition of cyclooxygenase isoenzymes in New Zealand white rabbits (Oryctolagus cuniculus) by the Non‐Steroidal anti‐inflammato2
Bayesian‐based withdrawal estimates using pharmacokinetic parameters for two capsaicinoid‐containing products administered to horses2
Pharmacokinetics of diphenhydramine following single‐dose intravenous and oral administration in non‐fasted adult horses2
Ivermectin induces chicken BCRP/ABCG2 expression and function: Involvement of CXR signaling pathway and mRNA stabilization2
Pharmacokinetics and pulmonary distribution of Draxxin® (tulathromycin) in healthy adult horses2
Disposition kinetics of robenacoxib following intravenous and oral administration in geese (Anser anser domesticus)2
Application of pharmacokinetic/pharmacodynamic concepts to the development of treatment regimens for sporadic canine urinary tract infections: Challenges and paths forward2
The history and pharmacology of buprenorphine: New advances in cats1
Evaluation of signal detection algorithms within the Elanco Animal Health Pharmacovigilance database1
Pharmacokinetic evaluation of oral deracoxib in geese (Anser anser domesticus)1
Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1‐deficient collie dogs1
Control of ticks on horses using abamectin‐impregnated ear tags. A pharmacokinetic and pharmacodynamic study1
Pharmacokinetic, sedative, and physiological effects of oral compounded formulations of trazodone alone or in combination with gabapentin in male cats1
Pharmacokinetics of maropitant citrate in Rhode Island Red chickens (Gallus gallus domesticus) following subcutaneous administration1
Pharmacokinetics and pharmacodynamics of intravenous continuous rate infusion and repeated intramuscular administration of dexmedetomidine in standing horses1
Pharmacokinetics of levofloxacin mesylate in healthy adult giant panda after single‐dose administration via different routes1
Therapeutic efficacy of enrofloxacin in treatment of Francisella orientalis infections in juvenile Nile tilapia (Oreochromis niloticus L.)1
Pharmacokinetic properties of abamectin after oral administration in dogs1
Characterization of P‐glycoprotein orthologs from human, sheep, pig, dog, and cat1
The effect of doxapram on survival and APGAR score in newborn puppies delivered by elective caesarean: A randomized controlled trial1
Anticoagulant profile of subcutaneous enoxaparin in healthy dogs1
Plasma concentrations of diclazuril following oral administration of diclazuril and diclazuril sodium salt to cattle1
Modulation of monepantel secretion into milk by soy isoflavones1
In vivo joint synovial fluid disposition of a novel sustained‐release formulation of diclofenac and hyaluronic acid in horses1
Cebranopadol, a novel first‐in‐class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits1
Pharmacokinetics of intramuscular maropitant in pigs (Sus scrofa domesticus)1
Evaluation of partial area under the curve in bioequivalence studies using destructive sampling design1
Diagnostic clinical microbiology1
Multicentered masked placebo‐controlled phase 3 clinical study of an extended duration transdermal buprenorphine solution for post‐operative pain in cats1
Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial1
Pharmacokinetics and pharmacokinetic interactions of orally administered oxfendazole and oxyclozanide tablet formulation to sheep1
Pharmacokinetics of xylazine after 2‐, 4‐, and 6‐hr durations of continuous rate infusions in horses1
Pharmacokinetic profiles of clarithromycin in freshwater crocodiles (Crocodylus siamensis)1
Pharmacokinetics of doxycycline in dogs1
Pharmacokinetics and pharmacodynamics of oral and intravenous metoprolol tartrate in clinically healthy horses1
Pharmacokinetics of intra‐articular buprenorphine in horses with lipopolysaccharide‐induced synovitis1
Pharmacokinetics of orally administered single‐dose ponazuril in cats1
A validated UPLC‐MS/MS method for quantification of glutamine in plasma and pharmacokinetic study of oral glutamine tablets in healthy Beagles1
Pharmacokinetics of a single dose of oclacitinib maleate as a top dress in adult horses1
Plasma pharmacokinetics, pulmonary disposition, and safety of subcutaneous gamithromycin in alpacas1
Pharmacokinetic Profiles of Metamizole Metabolites after Intramuscular and Intravenous Administration in Healthy Arabian Horses1
Can diarrhea affect the pharmacokinetics of racecadotril in neonatal calves?1
Pharmacokinetics and bioavailability of carprofen in sheep1
Preliminary bioequivalence of an oral integrating film formulation containing meloxicam with a suspension formulation in beagle dogs1
Pharmacokinetics of oral and compounded intravenous gabapentin in Duroc swine (SusScrofa)1
Pharmacokinetics and therapeutic efficacies of fenbendazole in comparison with levamisole in helminth‐infected Caspian turtles (Mauremys caspica)1
Development and application of a physiologically based pharmacokinetic model for orbifloxacin in crucian carp (Carassius auratus)1
Multicentered masked placebo‐controlled phase 2 clinical study of an extended duration transdermal buprenorphine solution for postoperative pain in cats1
Single‐dose pharmacokinetics of mycophenolic acid following administration of immediate‐release mycophenolate mofetil in healthy Beagle dogs1
Canine orosomucoid (alpha‐1 acid glycoprotein) variants and their influence on drug plasma protein binding1
Pharmacokinetics of danofloxacin in freshwater crocodiles (Crocodylus siamensis) after intramuscular injection1
Comparative pharmacokinetics and pharmacokinetic/pharmacodynamic analysis by nonlinear mixed‐effects modeling of cefquinome in nonpregnant, pregnant, and lactating goats after intravenous and intramus1
Pharmacokinetic profile and effect on the faecal microbiome of a single dose of pradofloxacin oral suspension in the rabbit (Oryctolagus cuniculus)1
The publication of studies involving the use of human critically important antimicrobial agents in veterinary species1
Urinary cortisol metabolites are reduced in MDR1 mutant dogs in a pilot targeted GC‐MS urinary steroid hormone metabolome analysis1
Pharmacokinetic properties of tramadol and M1 metabolite in Northeast Brazilian donkeys (Equus asinus)1
Phenylbutazone pharmacokinetics in southern white rhinoceros (Ceratotherium simum simum) after oral administration1
Effects of vatinoxan on xylazine‐induced pulmonary alterations in sheep1
Pharmacokinetics of extended‐release ivermectin microspheres after oral administration to healthy pigs1
Cytochrome P450 reaction phenotyping of itraconazole hydroxylation in the dog1
Pharmacokinetics of carprofen following single and repeated intravenous administrations of different doses in sheep1
Pharmacokinetics of toltrazuril and its metabolite, toltrazuril sulfone, in suckling piglets following oral and intramuscular administrations1
Pharmacokinetics and tissue concentrations of firocoxib in sows following oral administration1
Pharmacokinetics and residue elimination of norfloxacin in rainbow trout (Oncorhynchus mykiss)1
0.089475154876709